Troy Corporation announced an increase in prices of all Micropel OBPA (oxybisphenoxarsine) antimicrobial products by up to 15 percent effective June 15, 2012, or as contracts allow. This price increase is necessary due to escalation in the cost of raw materials, energy, labor, packaging, transportation and worldwide regulatory compliance the company said.